NCT05243394

Brief Summary

The study aims to compare the effects of treadmill gait training in a gamified virtual reality environment with tDCS versus treadmill gait training in a gamified virtual reality environment versus treadmill training in people with Parkinson's Disease.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
66

participants targeted

Target at P50-P75 for not_applicable parkinson-disease

Timeline
Completed

Started Jan 2023

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 20, 2022

Completed
28 days until next milestone

First Posted

Study publicly available on registry

February 17, 2022

Completed
11 months until next milestone

Study Start

First participant enrolled

January 1, 2023

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

November 7, 2022

Status Verified

November 1, 2022

Enrollment Period

1.2 years

First QC Date

January 20, 2022

Last Update Submit

November 2, 2022

Conditions

Keywords

Virtual RealityGamificationtDCSTreadmill gait trainingDual Task

Outcome Measures

Primary Outcomes (10)

  • Stride lenght

    Stride length will be recorded while walking on a 10-meter aisle with an inertial sensor system while the patient is asked to walk at preferred, very slow, slow, medium, high and very high speed. Will be measured in meters (m).

    14 weeks

  • Speed

    Speed will be recorded while walking on a 10-meter aisle with an inertial sensor system while the patient is asked to walk at preferred, very slow, slow, medium, high and very high speed. Will be measured in meters per second (m/s).

    14 weeks

  • Step cadence

    Step cadence will be recorded while walking on a 10-meter aisle with an inertial sensor system while the patient is asked to walk at preferred, very slow, slow, medium, high and very high speed. Will be measured in Hertz (Hz).

    14 weeks

  • Stride Length during Dual Task

    Stride length will be recorded while walking on a 10-meter aisle with an inertial sensor system while listening to an audio recording, in which patients will hear certain set words and will have to remember how many times they are mentioned (Phoneme Monitoring Paradigm Dual Task). Participants will be asked to walk at preferred speed. Will be measured in meters (m).

    14 weeks

  • Speed during Dual Task

    Speed will be recorded while walking on a 10-meter aisle with an inertial sensor system while listening to an audio recording, in which patients will hear certain set words and will have to remember how many times they are mentioned (Phoneme Monitoring Paradigm Dual Task). Participants will be asked to walk at preferred speed. Will be measured in meters per second (m/s).

    14 weeks

  • Step cadence during Dual Task

    Step cadence will be recorded while walking on a 10-meter aisle with an inertial sensor system while listening to an audio recording, in which patients will hear certain set words and will have to remember how many times they are mentioned (Phoneme Monitoring Paradigm Dual Task). Participants will be asked to walk at preferred speed. Will be measured in Hertz (Hz).

    14 weeks

  • Stride Length Variation Coeficient

    Based on standard deviation and mean values of Stride Length data, a new variable will be calculated to assess the variability of stride length in participants' gait. Formula will be the following: (Standard deviation/mean Stride Length)100

    14 weeks

  • Stride Length Variation Coeficient during Dual Task

    Based on standard deviation and mean values of Stride Length data, a new variable will be calculated to assess the variability of stride length in participants' gait. Formula will be the following (data from Dual Task variable): (Standard deviation/mean Stride Length)100

    14 weeks

  • Step Cadence Variation Coeficient

    Based on standard deviation and mean values of step cadence data during Dual Task, a new variable will be calculated to assess the variability of step cadence in participants' gait. Formula will be the following: (Standard deviation/mean Step Cadence)100

    14 weeks

  • Step Cadence Variation Coeficient during Dual Task

    Based on standard deviation and mean values of step cadence data during Dual Task, a new variable will be calculated to assess the variability of step cadence in participants' gait. Formula will be the following (data from Dual Task variable): (Standard deviation/mean Step Cadence)100

    14 weeks

Secondary Outcomes (6)

  • Total Cognitive Performance

    14 weeks

  • Unified Parkinson's Disease Rating Scale (UPDRS)

    14 weeks

  • Hoehn & Yahr

    14 weeks

  • Parkinson's Disease Questionnaire 39

    14 weeks

  • MiniBest Test

    14 weeks

  • +1 more secondary outcomes

Study Arms (3)

Gamified virtual reality environtment + tDCS + treadmill gait training

EXPERIMENTAL

The first group will follow an 18-session gait training protocol for 6 weeks. Duration of the sessions will progressively increase from 20 to 45 minutes from first session to last. They will be immersed in a gamified virtual reality environment in which they will interact with the in-game ambient by having their feet represented on the screen and move as their own on the treadmill. They will also receive tDCS for the first 20 minutes of each session.

Other: Gamified virtual reality treadmill gait training with tDCS

Gamified virtual reality environtment + treadmill gait training

EXPERIMENTAL

The second group will follow an 18-session gait training protocol for 6 weeks. Duration of the sessions will progressively increase from 20 to 45 minutes from first session to last. They will be immersed in a gamified virtual reality environment in which they will interact with the in-game ambient by having their feet represented on the screen and move as their own on the treadmill.

Other: Gamified virtual reality treadmill gait training

Treadmill gait training

ACTIVE COMPARATOR

The third group will follow an 18-session gait training protocol for 6 weeks. Duration of the sessions will progressively increase from 20 to 45 minutes from first session to last.

Other: Treadmill gait training

Interventions

Progressive treadmill gait training in a gamified virtual reality environment with tDCS

Gamified virtual reality environtment + tDCS + treadmill gait training

Progressive treadmill gait training in a gamified virtual reality environment

Gamified virtual reality environtment + treadmill gait training

Progressive treadmill gait training

Treadmill gait training

Eligibility Criteria

Age50 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Idiopathic Parkinson's Disease
  • Stage II - III in the Hoehn and Yahr Scale during ON state
  • Ability to walk for 10 minutes independently without stop

You may not qualify if:

  • Significant cognitive decline based on mini mental status examination (MMSE \<23)
  • Severe auditory or visual deficits
  • Other neurological/psychiatric conditions
  • Any kind of cardiovascular complications that contraindicates physical activity
  • Clinical history of any brain surgery or deep brain stimulation device

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Institut de Recerca Biomèdica de Lleida

Lleida, 25006, Spain

RECRUITING

Related Publications (9)

  • Yogev-Seligmann G, Hausdorff JM, Giladi N. The role of executive function and attention in gait. Mov Disord. 2008 Feb 15;23(3):329-42; quiz 472. doi: 10.1002/mds.21720.

    PMID: 18058946BACKGROUND
  • Shahed J, Jankovic J. Motor symptoms in Parkinson's disease. Handb Clin Neurol. 2007;83:329-42. doi: 10.1016/S0072-9752(07)83013-2. No abstract available.

    PMID: 18808920BACKGROUND
  • Mehrholz J, Kugler J, Storch A, Pohl M, Hirsch K, Elsner B. Treadmill training for patients with Parkinson Disease. An abridged version of a Cochrane Review. Eur J Phys Rehabil Med. 2016 Oct;52(5):704-713. Epub 2016 Mar 4.

    PMID: 26940123BACKGROUND
  • Dockx K, Bekkers EM, Van den Bergh V, Ginis P, Rochester L, Hausdorff JM, Mirelman A, Nieuwboer A. Virtual reality for rehabilitation in Parkinson's disease. Cochrane Database Syst Rev. 2016 Dec 21;12(12):CD010760. doi: 10.1002/14651858.CD010760.pub2.

    PMID: 28000926BACKGROUND
  • Schootemeijer S, van der Kolk NM, Ellis T, Mirelman A, Nieuwboer A, Nieuwhof F, Schwarzschild MA, de Vries NM, Bloem BR. Barriers and Motivators to Engage in Exercise for Persons with Parkinson's Disease. J Parkinsons Dis. 2020;10(4):1293-1299. doi: 10.3233/JPD-202247.

    PMID: 32925106BACKGROUND
  • Broeder S, Nackaerts E, Heremans E, Vervoort G, Meesen R, Verheyden G, Nieuwboer A. Transcranial direct current stimulation in Parkinson's disease: Neurophysiological mechanisms and behavioral effects. Neurosci Biobehav Rev. 2015 Oct;57:105-17. doi: 10.1016/j.neubiorev.2015.08.010. Epub 2015 Aug 20.

    PMID: 26297812BACKGROUND
  • Mirelman A, Rochester L, Reelick M, Nieuwhof F, Pelosin E, Abbruzzese G, Dockx K, Nieuwboer A, Hausdorff JM. V-TIME: a treadmill training program augmented by virtual reality to decrease fall risk in older adults: study design of a randomized controlled trial. BMC Neurol. 2013 Feb 6;13:15. doi: 10.1186/1471-2377-13-15.

    PMID: 23388087BACKGROUND
  • Bosch-Barcelo P, Climent-Sanz C, Martinez-Navarro O, Masbernat-Almenara M, Pakarinen A, Ghosh PK, Fernandez-Lago H. A treadmill training program in a gamified virtual reality environment combined with transcranial direct current stimulation in Parkinson's Disease: Study protocol for a randomized controlled trial. PLoS One. 2024 Jul 16;19(7):e0307304. doi: 10.1371/journal.pone.0307304. eCollection 2024.

  • Bosch-Barcelo P, Masbernat-Almenara M, Martinez-Navarro O, Tersa-Miralles C, Pakarinen A, Fernandez-Lago H. A gamified virtual environment intervention for gait rehabilitation in Parkinson's Disease: co-creation and feasibility study. J Neuroeng Rehabil. 2024 Jun 24;21(1):107. doi: 10.1186/s12984-024-01399-6.

MeSH Terms

Conditions

Parkinson Disease

Interventions

Transcranial Direct Current Stimulation

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Intervention Hierarchy (Ancestors)

Electric Stimulation TherapyTherapeuticsConvulsive TherapyPsychiatric Somatic TherapiesBehavioral Disciplines and ActivitiesElectroshockPsychological Techniques

Study Officials

  • Helena Fernández-Lago

    Universitat de Lleida

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Helena Fernández-Lago

CONTACT

Pere Bosch-Barceló

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The outcome measuring assessors will not know from which group any of the participants comes from, and will have no interaction with any of the interventions applied.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: 3 groups of 22 participants will each follow a different treatment option.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

January 20, 2022

First Posted

February 17, 2022

Study Start

January 1, 2023

Primary Completion

March 1, 2024

Study Completion

September 1, 2024

Last Updated

November 7, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations